AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2024
Feb 21, 2024
34129_dirs_2024-02-20_0300f62f-7b5d-45a0-badf-b2d8e9aa12d9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2024-02-15
Reporting Person: Karrels James (SVP, CFO and Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-15 | Common Stock | M | 15003 | — | Acquired | 206779 | Direct |
| 2024-02-15 | Common Stock | F | 5327 | $17.40 | Disposed | 201452 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-15 | Restricted Stock Unit | $0 | M | 15003 | Disposed | Common Stock (15003) | Direct |
Footnotes
F1: On February 15, 2023 the reporting person was granted 45,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
F2: Owned jointly with reporting person's wife.
More from MACROGENICS INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18